OBN Announces Top 5 Most-Read News Stories of 2022
The year 2022 has been a pretty exciting year, filled with innovation, and ground-breaking technological advancements in the ophthalmic industry, despite the ongoing shadow of the Covid-19 pandemic.
As the year wraps around, we prepared a list of the top 5 most-read news stories in 2022.
1- COVID-19 Can Affect Vision and Depth Perception, Study Finds
Researchers discovered that SARS-CoV-2 can infect the eye through the respiratory system, via the brain, and that the trigeminal nerves are vulnerable to the virus. The virus can infect the eye through nerve tissues at the back of the eye that play a role in the visual aspects of the eye and sending signals for visual purposes. The result of this retinal inflammation was a reduction in depth perception due to blurred vision.
Click to read the full news.
2- The Pineal Gland & The Eye Of Horus
The Eye of Horus has been used for many metaphors over the years, i.e., “Eye of the Mind, Third Eye, Eye of the Truth or Insight, the Eye of God Inside the Human Mind.” The ancient Egyptians, believed that the Eye of Horus has mystic powers, such as giving better vision, taste, smell, touch, hearing and wisdom.
Click the link to read the full news.
3- FDA Warns Patients about LASIK Eye Surgery Complications
The FDA has issued a draft guidance to ensure that both physicians and patients can understand information on the benefits and risks of LASIK devices. These recommendations are based on concerns that some patients may not be receiving or understanding information regarding the possible complications of LASIK surgery.
Click to read the full news.
4- Revolutionary Drug Treatment For Cataracts Shows Extremely Positive Lab Results
A revolutionary new treatment for cataracts has shown extremely positive results in laboratory tests, giving hope that the condition, which currently can only be cured with surgery, could soon be treated with drugs.
Click the link to read the full news.
5-Bloomberg: Novartis Mulls Selling Its Ophthalmology Unit
Novartis is considering selling its ophthalmology and respiratory units, a Bloomberg report said on Wednesday, citing people familiar with the matter. The company’s ophthalmology business might yield roughly $5 billion alone, and some private equity companies are already studying the businesses.
Click the link to read the full news.
